FluroTech, to be renamed Consolidated Aerospace Finance Corporation, Announces $22 Million Equity Financing
01. Mai 2024 17:30 ET
|
FluroTech Ltd.
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, May 01, 2024 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV:...
FluroTech Ltd. Announces Sale of Shares in FluroTest Diagnostic Systems Ltd. and Option Cancellation
03. Januar 2023 22:00 ET
|
FluroTech Ltd.
CALGARY, Alberta, Jan. 03, 2023 (GLOBE NEWSWIRE) -- FluroTech Ltd. (“FluroTech” or the “Company”) (TSXV: TEST) announces that it has entered into a Share Purchase Agreement (“Agreement”) to sell all...
FluroTech Announces Strategic Exit of COVID-19 Pandemic Testing Business
29. November 2022 07:00 ET
|
FluroTech Ltd.
CALGARY, Alberta, Nov. 29, 2022 (GLOBE NEWSWIRE) -- FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”) announces that it has decided to exit the pandemic and emerging disease...
FluroTech Provides Operational Update: Announces Pause on Further Development of its Pandemic and Emerging Disease Defense Platform
08. April 2022 19:30 ET
|
FluroTech Ltd.
CALGARY, Alberta, April 08, 2022 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (the “Company” or “FluroTech”), announces that it has decided to pause any further expenditures on...
FluroTest Provides System Development Update; Announces Further Progress Optimizing the Immunoassay for SARS-CoV-2 Detection
07. Dezember 2021 07:00 ET
|
FluroTech Ltd.
CALGARY, Alberta, Dec. 07, 2021 (GLOBE NEWSWIRE) -- FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems ("FluroTest" or The Company), a developer of...
FluroTest Provides System Development Update; Reports Point of Access Test System and Immunoassay for SARS-CoV-2 Detection is Fully Functional
19. November 2021 08:00 ET
|
FluroTech Ltd.
CALGARY, Alberta, Nov. 19, 2021 (GLOBE NEWSWIRE) -- FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems ("FluroTest" or The Company), a developer of...
FluroTest Provides System Development Update; Reports Saliva-based Point of Access Test System and Immunoassay for SARS-CoV-2 Detection is Fully Functional
16. September 2021 08:00 ET
|
FluroTech Ltd.
CALGARY, Alberta, Sept. 16, 2021 (GLOBE NEWSWIRE) -- FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems ("FluroTest" or The Company), a diagnostics...
FluroTest Announces Pre-Emergency Use Authorization Filing with FDA; Provides Executive Update on Program Progress
12. Juli 2021 08:00 ET
|
FluroTech Ltd.
CALGARY, Alberta, July 12, 2021 (GLOBE NEWSWIRE) -- FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems ("FluroTest" or The Company), a diagnostics...
FluroTest Diagnostic Systems Featured in Grand View Research Report Exploring Growth of COVID-19 Saliva Screening Test Potential Market
17. Juni 2021 08:00 ET
|
FluroTech Ltd.
CALGARY, Alberta, June 17, 2021 (GLOBE NEWSWIRE) -- FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems ("FluroTest" or The Company), a diagnostics...
FluroTech Announces Closing of Amalgamation
20. Mai 2021 10:30 ET
|
FluroTech Ltd.
CALGARY, Alberta, May 20, 2021 (GLOBE NEWSWIRE) -- FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a diagnostics technology leader in high output rapid antigen testing for...